about
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utilityNutritional protective mechanisms against gut inflammationProbiotics, prebiotics and synbiotics- a reviewProtective and pro-inflammatory roles of intestinal bacteriaEvidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes.Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats.High-fat diet reduces the formation of butyrate, but increases succinate, inflammation, liver fat and cholesterol in rats, while dietary fibre counteracts these effects.Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity.Role of the enteric microbiota in intestinal homeostasis and inflammationModulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?Combinatorial effects of diet and genetics on inflammatory bowel disease pathogenesis.Gut microbiota richness promotes its stability upon increased dietary fibre intake in healthy adults.Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity?Sex differences in gut fermentation and immune parameters in rats fed an oligofructose-supplemented dietβ2-1 Fructan supplementation alters host immune responses in a manner consistent with increased exposure to microbial components: results from a double-blinded, randomised, cross-over study in healthy adults.Effects of dietary postbiotic and inulin on growth performance, IGF1 and GHR mRNA expression, faecal microbiota and volatile fatty acids in broilersEffects of prebiotics on immune system and cytokine expression.Efficacy profiles for different concentrations of Lactobacillus acidophilus in experimental colitisIs metabolic stress a common denominator in inflammatory bowel disease?Why interleukin-10 supplementation does not work in Crohn's disease patients.Prebiotics: A Potential Treatment Strategy for the Chemotherapy-damaged Gut?Therapeutic Manipulation of the Microbiome in IBD: Current Results and Future Approaches.Products for the treatment of inflammatory bowel disease: a patent review (2013 - 2014).The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.1,4-Dihydroxy-2-naphthoic acid from Propionibacterium freudenreichii reduces inflammation in interleukin-10-deficient mice with colitis by suppressing macrophage-derived proinflammatory cytokines.Whole and fractionated yellow pea flours modulate insulin, glucose, oxygen consumption, and the caecal microbiome in Golden Syrian hamsters.Prebiotics as functional food ingredients preventing diet-related diseases.Lactulose mediates suppression of dextran sodium sulfate-induced colon inflammation by increasing hydrogen production.Modulation of Immune Function in Rats Using Oligosaccharides Extracted from Palm Kernel Cake.Evaluation of the hypocholesterolemic effect and prebiotic activity of a lentil (Lens culinaris Medik) extract.New prebiotics from rice bran ameliorate inflammation in murine colitis models through the modulation of intestinal homeostasis and the mucosal immune system.A Review of Prebiotics Against in Poultry: Current and Future Potential for Microbiome Research ApplicationsProbiotics in the Treatment of Colorectal CancerGut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol
P2860
Q26995672-A3558D82-EDC2-4318-AD92-B0FF112663EDQ27028202-A7A9DAC4-2F93-414E-9314-CC3D0DC48D31Q28087443-3BD63165-A30F-496B-8DC9-EDB4CCB99D26Q28273923-F8E1E1C5-98C6-4BB9-8D5D-7BB169C3EC8DQ34120699-5ABC7B7A-698D-4B88-B0FC-A8E0897608EDQ34716086-CC9E6A0D-503D-4C97-8F85-2FED7D8333B0Q35043961-B985FE7E-65C8-4D90-8C27-DE4DEFBEFDB0Q35049771-E8FDEBFE-840C-459A-885E-9FECC09DFF78Q35052712-82176D23-39AE-49F1-B334-686977B51455Q35195891-70244E6E-FFB8-4727-A30F-9B34B6E40FDFQ35196243-DFC3A57B-3C68-4CE1-A4D5-F9D5120E9FA1Q35733844-AAA2D0A8-DB98-4944-9012-DD7C9641CA0AQ35786074-F0DE34C5-9428-4B4B-A098-B98DC2BA22C2Q35923688-A3DE26D7-382F-449A-8F6C-664A033067D4Q35961488-23EFC56C-390A-495C-820A-C2F62AD6D042Q36096468-8D5BF000-655A-4A3C-8986-C8DF928B15BBQ36153249-95E6DA77-7D4C-4894-86F4-DD8E861F2025Q37118873-5A5E6D94-EFBB-4FAA-85FA-765B8E3433E6Q37914788-E6C70235-C531-4A7E-8D35-FD4094FCE98CQ38120519-385B0139-A36E-4F00-BFEE-F1FE219BAC9FQ38243820-D9D83177-C126-4D07-995C-47AD6965EDF3Q38321531-F1CC0F85-A88E-4D0B-8C1F-631AA777B610Q38461139-C7F7C003-5F38-4364-8367-69C591C3C37BQ38661453-2F1E25E7-7756-4929-9A86-B6029BE7ABA2Q39134893-24EFCD10-DD88-4E83-A748-DDC2B3D37655Q39693787-E5036C2A-4421-4278-BC15-DB31DFC5F079Q39933158-320F3E11-4E26-4A09-9CBD-0F661A6038E3Q46018290-279E984F-D86C-4E90-802D-E850F7A05C1AQ48213775-93FD179B-58CE-44B5-8A5D-017F2D2CE525Q50523977-2F3A441E-3073-4102-BAFE-D29056007C7BQ51545790-6116130B-4951-4635-9302-E683BB2FDE21Q57169228-1CEC9BF2-AB28-479A-BF76-9ABEF2CF8805Q58758333-E84D9204-1ABD-4AEC-99E2-ACE32B7F8123Q58798926-5E5174AE-C472-49D1-A812-10D469191EBD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prebiotics in chronic intestinal inflammation.
@en
Prebiotics in chronic intestinal inflammation.
@nl
type
label
Prebiotics in chronic intestinal inflammation.
@en
Prebiotics in chronic intestinal inflammation.
@nl
prefLabel
Prebiotics in chronic intestinal inflammation.
@en
Prebiotics in chronic intestinal inflammation.
@nl
P2860
P356
P1476
Prebiotics in chronic intestinal inflammation.
@en
P2093
Levinus A Dieleman
Mirjam A C Looijer-van Langen
P2860
P304
P356
10.1002/IBD.20737
P577
2009-03-01T00:00:00Z